IMRX:NASDAQ
Immuneering Corp
၄.၁၇ US$
arrow_downward
-၀.၄၈%(-၀.၀၂၀) 1D
ဇွန် ၁၆, GMT-၄ ၁၀:၀၀:၄၈ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMRX...
Open
၄.၁၉ US$
High
၄.၂၉ US$
Low
၄.၁၆ US$
Mkt. cap
၂၇.၁၁ ကုဋေ
Avg. vol.
၁.၈၄ သန်း
Volume
၈.၄၈ သောင်း
52-wk high
၁၀.၀၈ US$
52-wk low
၁.၆၆ US$
EPS
-၁.၁၇ US$
Beta
၀.၃၈
Shares outstanding
၆.၄၇ ကုဋေ
No. of employees
၅၅
Open
၄.၁၉ US$
High
၄.၂၉ US$
Low
၄.၁၆ US$
Mkt. cap
၂၇.၁၁ ကုဋေ
Avg. vol.
၁.၈၄ သန်း
Volume
၈.၄၈ သောင်း
52-wk high
၁၀.၀၈ US$
52-wk low
၁.၆၆ US$
EPS
-၁.၁၇ US$
Beta
၀.၃၈
Shares outstanding
၆.၄၇ ကုဋေ
No. of employees
၅၅
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to IMRX in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current ၄.၁၇ US$
၂၀.၀၀ US$ (+၃၇၉.၆၂%)
Average
၁၃.၇၅ US$ (+၂၂၉.၇၄%)
Lowest
၁၁.၀၀ US$ (+၁၆၃.၇၉%)
News stories
From sources across the web
TipRanks
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Immuneering Appoints Veteran Biotech Leader as New CFO
Traders Union
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Andrew Gengos joins Immuneering as new chief financial officer
www.marketscreener.com
·
ပြီးခဲ့သည့် ၁ ရက်
Immuneering Corporation Announces Appointment of Andrew Gengos to Chief Financial Officer, Effective July 16, 2026
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Immuneering names Andrew Gengos as chief financial officer
About Immuneering Corp
AI content may include mistakes. Learn more